Vir Biotechnology, Inc. (NASDAQ:VIR) Shares Could Be 26% Below Their Intrinsic Value Estimate

Retrieved on: 2023-01-07 15:04:34

Tags for this article:

Click the tags to see associated articles and topics

Vir Biotechnology, Inc. (NASDAQ:VIR) Shares Could Be 26% Below Their Intrinsic Value Estimate. View article details on hiswai:

Excerpt

Key Insights Vir Biotechnology's estimated fair value is US$35.0 based on 2 Stage Free Cash Flow to Equity Current...

Article found on: simplywall.st